Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DTRX | ISIN: US92854B1098 | Ticker-Symbol: U5P
Tradegate
06.02.26 | 12:33
1,070 Euro
-0,93 % -0,010
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVANI MEDICAL INC Chart 1 Jahr
5-Tage-Chart
VIVANI MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0701,11006.02.
1,0601,11006.02.

Aktuelle News zur VIVANI MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.01.Vivani Medical, Inc.: Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026128Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology Cortigent is the only company to have obtained FDA approval of a device providing artificial...
► Artikel lesen
27.01.Vivani Medical, Inc. Announces Closing of Common Stock Offering4
27.01.Vivani Medical, Inc. - 8-K, Current Report3
26.01.Vivani Medical prices common stock offering1
26.01.Vivani Prices Common Stock Offering At $1.48/Shr-
26.01.Vivani Medical prices $4.5 million stock offering at $1.48 per share3
26.01.Vivani Medical, Inc. Announces Pricing of Common Stock Offering1
22.01.Vivani Medical, Inc.: Vivani Subsidiary Cortigent to Present Orion System's Advanced Brain Implant Technology in Poster Session at NANS 20261
VIVANI MEDICAL Aktie jetzt für 0€ handeln
13.11.25Vivani Medical GAAP EPS of -$0.11 in-line1
13.11.25Vivani Medical, Inc.: Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results201Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to enable rapid initiation of Phase...
► Artikel lesen
13.11.25Vivani Medical, Inc. - 10-Q, Quarterly Report-
13.11.25Vivani Medical, Inc. - 8-K, Current Report-
10.11.25VIVANI stellt neue Bio-Schololade aus der ganzen Kakaofrucht vor2
28.10.25Vivani Medical, Inc. Announces Closing of Common Stock Offering4
28.10.25Vivani Medical, Inc. - 8-K, Current Report-
27.10.25Vivani Medical prices $16M offering at $1.62 per share3
27.10.25Vivani Medical prices $15.7 million stock offering at $1.62 per share1
27.10.25Vivani Medical, Inc. Announces Pricing of Common Stock Offering1
03.10.25Vivani delays Cortigent spin-off record date due to government shutdown2
03.10.25Vivani Medical, Inc. - 8-K, Current Report1
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1